Abstract: The aim of this study was to discuss the Elevated ST segment in ECG in myocardial infarction (MI), and especially after thrombolysis treatment with streptokinase, also to overview the mechanisms of streptokinase as anticoagulant in MI. A computerized search was conducted through electronic medical databases (PubMed/Midline, Embase, and science-direct) for relevant trails, and articles that were published in English language up to December 17th 2016, and involving human subject. We used following medical heading in our electronic search through mentioned databases; “ST elevation” And “Myocardial infarction” OR “MI”, “thrombolysis” “streptokinase”. Significant advances in the early detection and reperfusion techniques of acute MI have caused a considerable decrease in morbidity and mortality. To even more optimize the medical outcome in these patients, many efforts have actually been geared towards cardioprotection against myocardial reperfusion injury with mechanical. Cloning of the SK gene in non-pathogenic microorganisms has enabled production of recombinant SK that gets rid of any risk of inadvertent inoculation of patients and production personnel with potentially pathogenic Streptococci. SK can be produced inexpensively in bulk by means of bacterial fermentation espically in MI and therapy of STEMI.
Keywords: Streptokinase, myocardial infarction.
Title: Acute ST Elevation Myocardial Infarction Thrombolysed with Streptokinase
Author: Abdullah Osamah Samanudi, Baraa Mohammed Alim, Ahmed Taher Alsulaimani, Ghaida Mohammed Bawazeer, Abdulrahman Mohammed Alshehri, Abdulrahman Ghazi Allahyani
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
